Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Comprehensive analysis of the functional microRNA-mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression.

Li Y, Xu J, Chen H, Bai J, Li S, Zhao Z, Shao T, Jiang T, Ren H, Kang C, Li X.

Nucleic Acids Res. 2013 Dec;41(22):e203. doi: 10.1093/nar/gkt1054. Epub 2013 Nov 4.

2.

miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.

Liu J, Xu J, Li H, Sun C, Yu L, Li Y, Shi C, Zhou X, Bian X, Ping Y, Wen Y, Zhao S, Xu H, Ren L, An T, Wang Q, Yu S.

Oncotarget. 2015 Oct 6;6(30):29129-42. doi: 10.18632/oncotarget.4895.

3.

MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis.

Yan W, Li R, Liu Y, Yang P, Wang Z, Zhang C, Bao Z, Zhang W, You Y, Jiang T.

Oncotarget. 2014 Dec 30;5(24):12908-15.

4.

Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.

Pang C, Guan Y, Zhao K, Chen L, Bao Y, Cui R, Li G, Wang Y.

Int J Clin Exp Pathol. 2015 May 1;8(5):4943-52. eCollection 2015.

5.

Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.

Yerukala Sathipati S, Huang HL, Ho SY.

BMC Genomics. 2016 Dec 22;17(Suppl 13):1022. doi: 10.1186/s12864-016-3321-y.

6.

Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network.

Cao Y, Wang P, Ning S, Xiao W, Xiao B, Li X.

Oncotarget. 2016 Jul 5;7(27):41737-41747. doi: 10.18632/oncotarget.9569.

7.

A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.

Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G, Pelosi A, Rizzo MG.

J Exp Clin Cancer Res. 2016 Jul 30;35(1):124. doi: 10.1186/s13046-016-0393-0.

8.

High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.

Guan Y, Chen L, Bao Y, Qiu B, Pang C, Cui R, Wang Y.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):6576-88. eCollection 2015.

9.

MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.

Delic S, Lottmann N, Stelzl A, Liesenberg F, Wolter M, Götze S, Zapatka M, Shiio Y, Sabel MC, Felsberg J, Reifenberger G, Riemenschneider MJ.

Neuro Oncol. 2014 Jan;16(2):179-90. doi: 10.1093/neuonc/not164. Epub 2013 Dec 4.

10.

Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas.

Wang S, Jiao B, Geng S, Song J, Liang Z, Lu S.

J Neurol Sci. 2014 Mar 15;338(1-2):71-6. doi: 10.1016/j.jns.2013.12.019. Epub 2013 Dec 15.

PMID:
24380686
11.

MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes.

Liu F, Gong J, Huang W, Wang Z, Wang M, Yang J, Wu C, Wu Z, Han B.

Oncogene. 2014 Oct 2;33(40):4813-22. doi: 10.1038/onc.2013.428. Epub 2013 Oct 28.

PMID:
24166509
12.

The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma.

Chen L, Zhang W, Yan W, Han L, Zhang K, Shi Z, Zhang J, Wang Y, Li Y, Yu S, Pu P, Jiang C, Jiang T, Kang C.

Carcinogenesis. 2012 Nov;33(11):2276-82. doi: 10.1093/carcin/bgs261. Epub 2012 Aug 7.

PMID:
22871495
13.

Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.

Ye S, Yang L, Zhao X, Song W, Wang W, Zheng S.

Cell Biochem Biophys. 2014 Dec;70(3):1849-58. doi: 10.1007/s12013-014-0142-y.

PMID:
25087086
14.

Increased expression of microRNA-9 predicts an unfavorable prognosis in human glioma.

Wu Z, Wang L, Li G, Liu H, Fan F, Li Z, Li Y, Gao G.

Mol Cell Biochem. 2013 Dec;384(1-2):263-8.

PMID:
24122417
15.

Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.

Guan Y, Chen L, Bao Y, Pang C, Cui R, Li G, Liu J, Wang Y.

Int J Clin Exp Pathol. 2015 Jan 1;8(1):727-34. eCollection 2015.

16.

A miRNA signature for defining aggressive phenotype and prognosis in gliomas.

Barbano R, Palumbo O, Pasculli B, Galasso M, Volinia S, D'Angelo V, Icolaro N, Coco M, Dimitri L, Graziano P, Copetti M, Valori VM, Maiello E, Carella M, Fazio VM, Parrella P.

PLoS One. 2014 Oct 3;9(10):e108950. doi: 10.1371/journal.pone.0108950. eCollection 2014.

17.

Bioinformatics analysis of miRNA expression profile between primary and recurrent glioblastoma.

Bo LJ, Wei B, Li ZH, Wang ZF, Gao Z, Miao Z.

Eur Rev Med Pharmacol Sci. 2015 Oct;19(19):3579-86.

18.
19.

Microarray analysis of the aberrant microRNA expression pattern in gliomas of different grades.

Zhu XP, Mou KJ, Xu QF, Tang JH, Huang GH, Xu JP, Li GH, Ai SJ, Hugnot JP, Zhou Z, Lv SQ.

Oncol Rep. 2015 Jul;34(1):318-24. doi: 10.3892/or.2015.3953. Epub 2015 May 6.

PMID:
25954994
20.

Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.

Li Z, Peng Z, Gu S, Zheng J, Feng D, Qin Q, He J.

Anticancer Res. 2017 Aug;37(8):4455-4468.

PMID:
28739740

Supplemental Content

Support Center